Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.
about
Antitumor Activity of RXDX-105 in Multiple Cancer Types with RET Rearrangements or Mutations.Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a reviewA novel multi-target inhibitor harboring selectivity of inhibiting EGFR T790M sparing wild-type EGFR.Understanding and targeting resistance mechanisms in NSCLC.In vitro and in vivo anti-tumor activity of alectinib in tumor cells with NCOA4-RET.Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.Non-mammalian models of multiple endocrine neoplasia type 2.The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling.Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1.Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.Drug resistance profiles of mutations in the RET kinase domainPersonalized therapy for lung cancer: Striking a moving target
P2860
Q38724603-3B0C7F88-A366-41CD-B596-31D3EF8878A2Q41292062-7D7AB1B3-D84A-424C-A70A-C7AB2B8952D6Q42367902-AA50EC87-0B66-40FD-9F8F-D4DB02655684Q46915997-6A966BBE-ADF6-4C66-A28E-4DA0C166B704Q47104655-6FD4F418-BA08-4419-87B1-8D8CE313D48FQ47601932-68251BFD-31B2-4D71-87F6-852483AA28F1Q47724734-BDE4C109-461A-48C6-84F5-B8511FDA22FEQ50085302-E44BCE39-A403-4301-9F05-4483FB8F032EQ51004850-2694CDB3-E50C-4A34-B6E0-85FDD0681678Q52312436-6995B82C-DD22-49BA-8667-37344B939BDFQ53694673-81358AB3-F539-4DC4-8E40-4E470C93D793Q55314894-DDBA518B-8245-44AB-BC2C-3C296551750EQ58044610-9A37C6F1-90ED-40F5-8F0B-98CAE6717F91Q58792324-0C5C1E90-B1DE-4BA6-806E-250A11F92819
P2860
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.
@en
type
label
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.
@en
prefLabel
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.
@en
P2093
P2860
P1476
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.
@en
P2093
Chengliu Jin
Eric B Haura
Gary V Martinez
Kar-Ming Fung
Lichao Zhao
Mikalai M Budzevich
Noreen Luetteke
Qingling Huang
Rikesh J Makanji
P2860
P304
P356
10.1158/1535-7163.MCT-16-0258
P577
2016-08-05T00:00:00Z